Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a life‐threatening condition with a heterogeneous clinical presentation. The recent availability of treatment for ATTR‐CM has stimulated increased awareness of the disease and patient identification. Stratification of patients with ATTR‐CM is critica...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Heart Fail
Main Authors: Garcia‐Pavia, Pablo, Bengel, Frank, Brito, Dulce, Damy, Thibaud, Duca, Franz, Dorbala, Sharmila, Nativi‐Nicolau, Jose, Obici, Laura, Rapezzi, Claudio, Sekijima, Yoshiki, Elliott, Perry M.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd. 2021
Assuntos:
Reviews
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239846/
https://ncbi.nlm.nih.gov/pubmed/33915002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2198
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares